Assessment of the Diagnostic Potential of Lecithin-Cholesterol Acyltransferase in Non-Alcoholic Fatty Liver Disease
Al Mustansiriyah Journal of Pharmaceutical Sciences · 30.06.2026 · 26 (2) · 234-247
DOI: 10.32947/ajps.v26i2.1357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al Mustansiriyah Journal of Pharmaceutical Sciences, online erschienen am 30.06.2026. Verfasst von Sara Mazin Muhammed Ali und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic liver disorder characterized by fat accumulation in hepatocytes. Lecithin-cholesterol acyltransferase (LCAT) is a liver-derived enzyme involved in lipid metabolism and may serve as a biomarker of hepatic metabolic function. The current study aimed to assess serum LCAT level in NAFLD patients in comparison with matched controls and to estimate its diagnostic potentials for NAFLD and its predictive potentials in relation to steatosis and fibrosis severity. A case-control study was conducted on 90 individuals, 45 NAFLD patients and 45 age-, sex-, and BMI-matched controls. LCAT level were measured using ELISA. Clinical data, including lipid profile, liver enzymes were recorded. Fibrosis risk was assessed using FIB-4 index, and transabdominal ultrasound was used for steatosis grading. NAFLD patients had significantly lower level of LCAT than control group participants (p < 0.001). However, serum LCAT level was not significantly associated with the severity of steatosis or fibrosis risk in NAFLD patients. Receiver operating characteristic curve analysis showed that LCAT has an excellent diagnostic potential, with an AUC of 0.951, sensitivity of 0.978 and specificity of 0.911 (p < 0.001). In conclusion, LCAT may serve as promising non-invasive diagnostic biomarkers for NAFLD.
Zitieren
APA
Ali, S. M. M., Kasim, A. A., & Al-Rikabi, M. H. (2026). Assessment of the Diagnostic Potential of Lecithin-Cholesterol Acyltransferase in Non-Alcoholic Fatty Liver Disease. Al Mustansiriyah Journal of Pharmaceutical Sciences, 26(2), 234-247. https://doi.org/10.32947/ajps.v26i2.1357
Vancouver
Ali SMM, Kasim AA, Al-Rikabi MH. Assessment of the Diagnostic Potential of Lecithin-Cholesterol Acyltransferase in Non-Alcoholic Fatty Liver Disease. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2026;26(2):234-247. doi:10.32947/ajps.v26i2.1357
BibTeX
@article{Ali2026,
author = {Ali, Sara Mazin Muhammed and Kasim, Ali Abdulhussain and Al-Rikabi, Mohammed H.},
title = {Assessment of the Diagnostic Potential of Lecithin-Cholesterol Acyltransferase in Non-Alcoholic Fatty Liver Disease},
journal = {Al Mustansiriyah Journal of Pharmaceutical Sciences},
year = {2026},
volume = {26},
number = {2},
pages = {234--247},
doi = {10.32947/ajps.v26i2.1357}
}
EUVIMED